When deciding what to do about PBM contracts up for renewal in 2020, “stay the course” appears to have been employers’ prevailing strategy, industry analysts say. But that approach could be poised to change in the future as firms evaluate the merits of greater medical and drug benefit integration.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.